A large body of research identifies associations between physiological and psychological symptoms. A systematic review of 31 studies, including 16 922 patients, found that objective physiological measures of health as well as medical diagnoses were strongly correlated with anxiety and depression.^[@bibr1-2515690X18823691]^ A meta-analysis of 244 studies found an association between psychological symptoms and somatic syndromes.^[@bibr2-2515690X18823691]^ A large-scale international study of 25 916 patients at 15 primary care centers in 14 countries on 5 continents found a significant association *(P* = .002) between depression and somatic symptoms in 69% of patients.^[@bibr3-2515690X18823691]^ Many other studies of specific conditions identify links between levels of psychological well-being and physiological measures of health.

Emotional Freedom Technique (EFT) is a novel therapy that combines both cognitive and somatic elements (described below). Systematic reviews and meta-analyses have demonstrated its efficacy for both physiological and psychological symptoms.^[@bibr4-2515690X18823691],[@bibr5-2515690X18823691]^ A current research bibliography lists more than 100 studies published in peer-reviewed journals ([Research.EFTuniverse.com](http://Research.EFTuniverse.com)). Its efficacy extends across a wide sample of populations, including college students,^[@bibr6-2515690X18823691]^ veterans,^[@bibr7-2515690X18823691],[@bibr8-2515690X18823691]^ pain patients,^[@bibr9-2515690X18823691],[@bibr10-2515690X18823691]^ overweight individuals,^[@bibr11-2515690X18823691][@bibr12-2515690X18823691]--[@bibr13-2515690X18823691]^ hospital patients,^[@bibr14-2515690X18823691],[@bibr15-2515690X18823691]^ athletes,^[@bibr16-2515690X18823691],[@bibr17-2515690X18823691]^ health care workers,^[@bibr18-2515690X18823691]^ gifted students,^[@bibr19-2515690X18823691]^ chemotherapy patients,^[@bibr20-2515690X18823691]^ and phobia sufferers.^[@bibr21-2515690X18823691][@bibr22-2515690X18823691]--[@bibr23-2515690X18823691]^ When measured against the standards of the American Psychological Association's Division 12 Task Force on Empirically Validated Treatments, EFT is found to be an "evidence-based" practice for anxiety, depression, phobias, and posttraumatic stress disorder (PTSD).^[@bibr4-2515690X18823691],[@bibr5-2515690X18823691]^

Emotional Freedom Techniques {#section1-2515690X18823691}
============================

Since its inception in 1995, EFT has been a manualized method,^[@bibr7-2515690X18823691],[@bibr24-2515690X18823691]^ leading to uniform application research, training, and clinical practice. EFT is a brief intervention combining elements of exposure, cognitive therapy, and somatic stimulation of acupressure points on the face and body. Participants typically identify a concern or issue they wish to address with the technique and rate their level of distress on a Likert-type scale out of 10 (10 is the maximum amount of distress and 0 represents the minimum or a neutral state). This is called a Subjective Unit of Distress (SUDS) scale and has long been used as a subjective measure of a participant's discomfort in therapy.^[@bibr25-2515690X18823691]^ Participants then state their concern in a "Setup Statement," which assists in turning them into their level of distress. This is typically stated in this format "Even though I have this problem (eg, anger), I deeply and completely accept myself." The first half of the setup statement emphasizes exposure, while the second half frames the traumatizing event in the context of self-acceptance. The participant then engages in the somatic tapping process on acupoints on the body while they repeat a shortened phrase to stay engaged (eg, feel angry). This is called the "Reminder Phrase." The tapping sequence uses 8 acupoints on the face and upper body and is normally repeated until the SUDS rating is very low (1 or 0).

Anxiety {#section2-2515690X18823691}
-------

EFT has been extensively investigated for anxiety and depression. In the first large-scale study of 5000 patients seeking treatment for anxiety across 11 clinics over a 5.5-year period, patients received either traditional anxiety treatment in the form of cognitive behavioral therapy (CBT), with medication if needed, or acupoint tapping with no medication.^[@bibr26-2515690X18823691]^ An improvement was found in 90% of patients who received acupoint tapping therapy compared to 63% of the CBT participants. Only 3 acupoint tapping sessions were needed before an individual's anxiety reduced, while an average of 15 was needed for CBT to show results. Complete relief of symptoms was seen in 76% of people in the acupoint taping group compared with 51% of people in the CBT group. One year later, the improvements seen were maintained by 78% of the acupoint group compared with 69% of the CBT group. Other studies also indicate equivalence or superiority to CBT.^[@bibr27-2515690X18823691][@bibr28-2515690X18823691]--[@bibr29-2515690X18823691]^

Similarly, a study of self-applied EFT for anxiety, depression, pain, and cravings in 216 health care workers resulted in significant improvements on all distress subscales and ratings of pain, emotional distress, and cravings following 2 hours of intervention, with gains maintained at follow-up. The severity and range of psychological symptoms was reduced, and greater subsequent use of EFT was associated with a steeper decrease in symptoms, although not in symptom range or breadth.^[@bibr18-2515690X18823691]^

A meta-analysis of 14 randomized controlled trials of EFT for anxiety disorders (n = 658) found a very large treatment effect of *d* = 1.23 (95% CI 0.82-1.64, *P* \< .001), while the effect size for combined controls was 0.41 (95% CI 0.17-0.67, *P* = .001). EFT treatment was associated with a significant decrease in anxiety scores, even when accounting for the effect size of control treatment.^[@bibr30-2515690X18823691]^

Depression {#section3-2515690X18823691}
----------

A meta-analysis of EFT for depression examined 20 studies.^[@bibr31-2515690X18823691]^ These included 8 outcome studies (n = 461) as well as 12 randomized controlled trials (n = 398). EFT demonstrated a very large effect size in the treatment of depression. Cohen's *d* across all studies was 1.31, with little difference between randomized controlled trials and uncontrolled outcome studies. Effect sizes at posttest, less than 90 days, and greater than 90 days were 1.31, 1.21, and 1.11, respectively, indicating durable maintenance of participant gains. EFT was more efficacious than physical interventions such as diaphragmatic breathing and as well as psychological interventions such as supportive interviews.^[@bibr31-2515690X18823691]^

The health care workers study also found a significant reduction in depression after EFT.^[@bibr18-2515690X18823691]^ A randomized controlled trial with a population of 59 veterans successfully treated for PTSD also identified a significant reduction in depressive symptoms after six 1-hour EFT sessions.^[@bibr32-2515690X18823691]^ Church et al^[@bibr6-2515690X18823691]^ reported that after brief group intervention using EFT for depression in 18 college students, those who received EFT were found to have significantly less depression than those who did not receive it, with an average depression score in the "nondepressed range" following treatment, compared to the control group who demonstrated no change in depressive symptoms. More recent research comparing EFT to CBT for 10 patients diagnosed with major depressive disorder, found after 8 weeks of group treatment (16 hours), both interventions produced significant reductions in depressive symptoms. The CBT group indicated a significant reduction postintervention, but this was not maintained over time. The EFT group however, showed a delayed effect of significant reductions in symptoms at 3- and 6-month follow-ups.^[@bibr27-2515690X18823691]^

Physiological Markers {#section4-2515690X18823691}
---------------------

The effect of EFT on medical diagnoses has been the subject of several studies. Chronic disease patients may benefit from a holistic health care and research has begun to consider the physiological changes that occur after EFT. A recent qualitative study that explored practitioners' experiences of using EFT to support chronic disease patients indicated that while EFT was one technique, "many emotions" emerged and "tapping on the physical" for pain perception, and negative emotions that may increase the perceived intensity and limiting impacts of physical pain were important.^[@bibr33-2515690X18823691]^

Other studies of physical conditions responding to EFT have included fibromyalgia,^[@bibr34-2515690X18823691]^ psoriasis,^[@bibr35-2515690X18823691]^ tension headaches,^[@bibr9-2515690X18823691]^ frozen shoulder,^[@bibr10-2515690X18823691]^ pulmonary injuries,^[@bibr36-2515690X18823691]^ chronic pain,^[@bibr37-2515690X18823691]^ chemotherapy side effects,^[@bibr20-2515690X18823691]^ traumatic brain injury,^[@bibr38-2515690X18823691]^ insomnia,^[@bibr39-2515690X18823691]^ and seizure disorders.^[@bibr40-2515690X18823691]^ Some studies of psychological symptoms have included a physiological measure. Church and Downs^[@bibr41-2515690X18823691]^ examined psychological trauma in athletes and also measured heart rate. Wells et al^[@bibr21-2515690X18823691]^ included pulse rate as a measure for phobia sufferers. Church et al^[@bibr42-2515690X18823691]^ performed a triple-blind randomized controlled trial comparing EFT to talk therapy and rest in a non-clinical sample of 83 participants. They found significant declines in the stress hormone cortisol. However, a trial with a smaller N did not have sufficient power to identify significant cortisol reductions.^[@bibr9-2515690X18823691]^ Two clinical case histories also report cortisol reductions.^[@bibr43-2515690X18823691],[@bibr44-2515690X18823691]^

The most revealing studies of the physiological aspects of EFT have examined its epigenetic effects. A population of veterans with PTSD received 10 EFT sessions.^[@bibr45-2515690X18823691]^ It found regulation of 6 genes associated with inflammation and immunity. A pilot study comparing an hour-long EFT session with placebo in 4 nonclinical participants found differential expression in 72 genes.^[@bibr46-2515690X18823691]^ These included genes associated with the suppression of cancer tumors, protection against ultraviolet radiation, regulation of type 2 diabetes insulin resistance, immunity from opportunistic infections, antiviral activity, synaptic connectivity between neurons, synthesis of both red and white blood cells, enhancement of male fertility, building white matter in the brain, metabolic regulation, neural plasticity, reinforcement of cell membranes, and the reduction of oxidative stress. The broad function of this suite of genes is similar to that found in Church et al,^[@bibr10-2515690X18823691]^ confirming the association of EFT with the downregulation of inflammation and stress markers and the upregulation of immune markers.

Generalizability {#section5-2515690X18823691}
----------------

The question of whether EFTs psychological effects are generalizable has been addressed in a number of studies. Wells et al^[@bibr21-2515690X18823691]^ original study of EFT for small animal phobias found that EFT produced greater decrease in intense fear of small animals than did a comparison breathing condition. A partial replication and extension by Baker and Sigel^[@bibr22-2515690X18823691]^ assessed whether such findings reflected (*a*) nonspecific factors common to many forms of psychotherapy, (*b*) some methodological artifact (such as regression to the mean, fatigue, or the passage of time), and/or (*c*) therapeutic ingredients specific to EFT. For most dependent variables, the EFT condition showed a significant decrease in fear of small animals immediately after, and again 1.38 years after, one 45-minute intervention, whereas a supportive interview and no-treatment condition did not.

The health care workers study^[@bibr18-2515690X18823691]^ found no significant difference between five 1-day workshops delivered by 2 different trainers. A replication of that study with EFT delivered by 5 different trainers in heterogenous settings noted the same effect.^[@bibr47-2515690X18823691]^ A study explicitly designed to determine EFTs generalizability compared effects in 2 heterogeneous groups.^[@bibr48-2515690X18823691]^ It found no significant difference.

EFT has been found efficacious in widely disparate groups, including hospital patients, war veterans, victims of sexual violence, school children, college students, teachers, health care workers, cancer patients, athletes, presurgery patients, mothers, dental patients, psychotherapists, diabetics, and survivors of natural disasters. Treatment time frames ranging from 15 minutes to ten 1-hour sessions have been successful. Studies have delivered EFT in a variety of formats, including online courses for weight loss and cravings (eg, Stapleton et al^[@bibr49-2515690X18823691]^) and self-administered EFT for fibromyalgia (Brattberg et al),^[@bibr34-2515690X18823691]^ via telephone sessions, in groups, and in individual counseling sessions. The breadth of populations, settings and delivery methods encompassed in these studies provides indication that EFTs effects can be considered generalizable.

Dismantling Studies {#section6-2515690X18823691}
-------------------

Because of the interest in the mechanism of change and active ingredient of EFT, several dismantling studies have been conducted. The first dismantling study included 119 university students and compared EFT points, sham points, and tapping on a doll, and also included a control group who did nothing.^[@bibr50-2515690X18823691]^ While significant reductions in self-reported fear occurred for all 3 tapping groups but not the nontapping group, the students used their forefinger to tap, which inadvertently stimulated an acupuncture point. The EFT group also included acupoints not in the typical process and omitted others, and the study did not use valid assessments nor full randomization to the groups.

A study of university students (EFT or a control group who received mindful breathing instead of tapping) found the EFT group reported more significant increases in enjoyment, hope, and pride and more significant decreases in anger, anxiety, and shame than did the breathing control group.^[@bibr51-2515690X18823691]^ However, the mindful breathing control group did not use the EFT setup or reminder statements, so while the actual tapping was the major difference to the control group, it was not the only difference.

The next study involved 56 university students who were assessed for stress symptoms and randomly allocated to an EFT group or a control group who tapped on sham points.^[@bibr52-2515690X18823691]^ The students reported a 39.3% reduction in stress symptoms in the EFT group but the sham tapping group only reported an 8.1% decrease. This study was, however, limited in that the stress questionnaire they used had not been validated and one of the investigators led both the experimental and control groups, possibly contaminating the results.

A 2015 study involved 126 school teachers (assessed for burnout risk) and is possibly the best dismantling study to date.^[@bibr53-2515690X18823691]^ A control group tapped on the left forearm, about an inch above the wrist, with the underside of the fingers of the open right hand. This was important because no finger points were used or unintentionally activated (as in the first study discussed). Everything else was identical. Results indicated the EFT group was superior to the sham points group on the 3 indicators of burnout being tracked (Emotional Exhaustion, Depersonalization, and Personal Accomplishment).

Finally, a recent meta-analysis of 6 dismantling or partial dismantling studies indicates that the acupuncture component is an essential ingredient, and not due to placebo, nonspecific effects of any therapeutic method, or non-acupressure components, in the rapid outcomes shown in EFT clinical trials.^[@bibr54-2515690X18823691]^

The Present Study {#section7-2515690X18823691}
=================

While the foregoing studies of physiological markers typically examine a cluster of diagnostic systems with EFT treatment, the current study sought to elucidate EFTs common underlying physiological mechanisms of action. The systems studied included the autonomic nervous system (ANS) by measuring heart rate variability (HRV) and heart coherence (HC); the circulatory system by assessing resting heart rate (RHR) and blood pressure (BP); the endocrine system by evaluating cortisol, and the immune system by examining levels of salivary immunoglobulin A (SigA). After successful training in emotional regulation, HC increases and a reduction (improvement) in HRV is found.^[@bibr55-2515690X18823691]^ The current study also assessed psychological symptoms of anxiety, depression, PTSD, pain, cravings, and happiness, and the relationship of psychological symptoms to physiological markers.

Based on prior research, it was hypothesized that EFT would result in significant decreases in the psychological constructs of anxiety, depression, PTSD, pain and cravings, as well as the physiological markers of HRV, cortisol, RHR, and BP. It was further hypothesized that an increase in happiness, immune response (SigA), HC, and would be identified.

The second hypothesis of the study was that psychological change would be robust and durable across a range of settings and instructors. If EFT effects were due to the intervention of a particularly gifted therapist, they should not be as robust in groups trained by other therapists. If, on the other hand, psychological improvement is found regardless of the individual delivering the training, or the setting in which it is delivered, it can be reasonably concluded that the effects measured are due to the clinical EFT method itself and not to some unique characteristic of a single individual or the stress-reducing effects of a unique setting.

Methods {#section8-2515690X18823691}
=======

The study included 203 participants at 6 Clinical EFT workshops. The workshops were taught by a variety of instructors trained and certified in Clinical EFT, the evidence-based form of the technique.^[@bibr7-2515690X18823691]^ To measure physiological change, participants at one of these workshops (n = 31) also received a comprehensive battery of medical tests. Psychological testing was similar at all 6 workshops, with pre- and postmeasures, and a follow-up during the subsequent year. Physiological measures were not assessed at follow-up since data collection was performed via email. [Table 1](#table1-2515690X18823691){ref-type="table"} represents the baseline characteristics of study participants at recruitment. The majority of participants were women (65%) older than 50 years.

###### 

Baseline Characteristics of Study Participants at Recruitment.

![](10.1177_2515690X18823691-table1)

  Demographic and Baseline Characteristics   Subjects    Male        Female
  ------------------------------------------ ----------- ----------- ------------
  N                                          203         30 (14.8)   170 (83.7)
  Age, years                                                         
   Mean                                      50.45       48.13       50.80
   Standard deviation                        12.35       14.76       11.96
   Min-Max                                   19-81       22-75       19-81
  Education, n (%)                                                   
   High school/College                       14 (6.9)    3           11
   University                                55 (27.1)   9           46
   Postgraduate                              86 (42.4)   15          71
   Unknown                                   48 (23.6)   3           42
  Posttraumatic stress disorder feelings                             
   Mean                                      2.54        2.57        2.51
   Standard deviation                        1.24        1.50        1.17
   Min-Max                                   1-5         1-5         1-5
  Pain                                                               
   Mean                                      4.09        3.54        4.16
   Standard deviation                        2.49        2.40        2.49
   Min-Max                                   0-10        0-8         0-10
  Happiness                                                          
   Mean                                      7.28        7.39        7.30
   Standard deviation                        2.10        2.41        2.03
   Min-Max                                   0-10        0-10        1-10
  Anxiety                                                            
   Mean                                      8.35        7.31        8.54
   Standard deviation                        3.85        3.95        3.82
   Min-Max                                   0-20        1-18        0-20
  Depression                                                         
   Mean                                      4.04        4.14        3.96
   Standard deviation                        3.18        3.29        3.07
   Min-Max                                   0-14        0-13        0-13
  Cravings                                                           
   Mean                                      6.47        5.71        6.64
   Standard deviation                        2.53        3.03        2.37
   Min-Max                                   0-10        0-10        0-10

Measures {#section9-2515690X18823691}
--------

Subjects were assessed for depression and anxiety using the Hospital Anxiety and Depression Scale (HADS; Zigmond et al).^[@bibr56-2515690X18823691]^ HADS includes 7 questions related to depression and seven questions related to anxiety. Each item is scored from 0 to 3 and the score is totaled. Thus, subjects can score from 0 to 21 for either anxiety or depression. Scores for the HADS were calculated for anxiety and depression separately. A score of \>8 for either is considered clinical. Happiness,^[@bibr57-2515690X18823691]^ pain,^[@bibr58-2515690X18823691]^ and cravings were assessed using an 11-item Likert-type scale (SUDS rating). PTSD was assessed with the 2-item form of the PTSD Checklist (PCL; Lang et al).^[@bibr59-2515690X18823691]^ All assessments are reliable and valid.

Blood pressure and heart rate were measured using a standard blood pressure cuff (Omron 3). HRV and HC were assessed using HeartMath Pro Plus hardware and software (HeartMath LLC, Boulder Creek, CA). Cortisol and SigA were assessed using saliva swabs (Sabre Labs, Capistrano, CA). Cortisol samples were collected at the same time pre and post (10 [am]{.smallcaps}) to eliminate variability due to circadian rhythms.

Cravings were assessed before and after a 1-hour module on the use of EFT for this topic. Participants were provided with chocolate and self-assessed their pretest level of craving (11-point SUDS rating scale). EFT was then used for several components of the experience of craving. These included the substance itself, emotions associated with the substance, early childhood experiences involving the substance, times at which craving levels increased, and emotional losses associated with the substance.

EFT Intervention {#section10-2515690X18823691}
----------------

All EFT instructors were trained and certified in Clinical EFT (EFT Universe, Fulton, CA). EFT was applied with fidelity to the third edition of *The EFT Manual*.^[@bibr60-2515690X18823691]^ Twelve hours of the workshop was devoted to clinical demonstrations, practice sessions, and feedback. EFT was delivered as peer-to-peer coaching, and symptoms assessed without attempting to diagnose or treat mental health conditions. A group delivery method known as "Borrowing Benefits" described in *The EFT Manual* ^[@bibr60-2515690X18823691]^ was used, in which EFT is administered to one individual while the remainder of the group simultaneously self-applies EFT. The settings included residential institutes, nonresidential institutes, hotel meeting rooms, and a university campus. The identical curriculum was used at all 6 workshops. Most were conducted over 4 days. Two were conducted at residential institutes in which the curriculum was delivered over the course of 5 days, with 2 half-days off, but the same number of instruction and practice hours.

Results {#section11-2515690X18823691}
=======

Participant scores for happiness, anxiety, depression, PTSD, pain, and cravings were compared before and after treatment using the Wilcoxon signed rank test for paired samples. In order to make the least number of assumptions about the data, it was deemed appropriate to use the nonparametric Wilcoxon signed rank test rather than *t* tests. Changes in BP, RHR, cortisol, SigA levels, HRV, and HC in a subsample of participants were also determined using the Wilcoxon signed rank test. All statistical analyses were performed using the SPSS statistical package version 24.

Between the pre- and posttest time points, participants experienced significant decreases in anxiety, depression, PTSD, pain, and cravings, and a significant increase in happiness (see [Table 2](#table2-2515690X18823691){ref-type="table"}). Not all participants completed all assessments at all time points, thus the *n* available for analysis is shown in the relevant rows of the appropriate tables.

###### 

Participant Outcome Measures Pre- Versus Postintervention.

![](10.1177_2515690X18823691-table2)

  Scale                                     Pretest, Mean ± SD   Posttest, Mean ± SD   Change in Mean   *Z* Statistic   *P*      Percent Change
  ----------------------------------------- -------------------- --------------------- ---------------- --------------- -------- ----------------
  Happiness (n = 170)                       7.28 ± 2.10          8.65 ± 1.72           1.37             −8.389          \<.000   18.82
  Anxiety (n = 170)                         8.35 ± 3.85          4.98 ± 3.43           −3.37            −9.963          \<.000   −40.36
  Depression (n = 170)                      4.04 ± 3.18          2.30 ± 2.28           −1.74            −8.282          \<.000   −43.07
  Posttraumatic stress disorder (n = 158)   4.74 ± 2.16          3.30 ± 1.49           −1.44            −7.793          \<.000   −30.38
  Pain (n = 168)                            4.09 ± 2.49          1.63 ± 1.89           −2.46            −9.325          \<.000   −60.15
  Cravings (n = 164)                        6.47 ± 2.53          1.81 ± 1.81           −4.66            −10.766         \<.000   −72.02

In the subset of participants in whom physiological indicators of health were assessed (n = 31), psychological measurements, including anxiety, depression, PTSD, pain, and cravings all improved. Physiological indicators, including RHR, BP, and cortisol also significantly decreased indicating a functional improvement (see [Table 3](#table3-2515690X18823691){ref-type="table"} and [Figure 1](#fig1-2515690X18823691){ref-type="fig"}). The changes corresponded with an increase in happiness (*P* = .0004) and immune function in the form of SigA secretion (*P* = .017). Though not statistically significant, a downward trend was observed for HRV and an upward trend for HC suggesting an improvement in cardiovascular health and ANS function.

###### 

Subset of Participants Outcomes Pre- Versus Postintervention (N = 31).

![](10.1177_2515690X18823691-table3)

  Scale                                       Pretest, Mean ± SD   Posttest, Mean ± SD   Change in Mean   *Z* Statistic   *P*      Percent Change
  ------------------------------------------- -------------------- --------------------- ---------------- --------------- -------- ----------------
  Happiness (n = 29)                          7.9 ± 1.92           9.03 ± 1.27           1.13             −2.736          .006     14.30
  Anxiety (n = 31)                            6.32 ± 3.89          3.84 ± 3.17           −2.48            −3.640          \<.000   −39.24
  Depression (n = 31)                         2.68 ± 2.29          1.45 ± 1.61           −1.23            −2.615          .009     −45.89
  PTSD (n = 28)                               4.59 ± 2.01          3.14 ± 1.46           −1.45            −2.934          .003     −31.59
  Pain (n = 29)                               3.9 ± 2.35           1.34 ± 1.69           −2.56            −3.856          \<.000   −65.64
  Cravings (n = 25)                           6.72 ± 2.73          1.36 ± 1.25           −5.36            −4.225          \<.000   −79.76
  Heart rate, beats/min (n = 29)              80.97 ± 12.04        74.59 ± 10.48         −6.38            −3.430          .001     −7.88
  Systolic blood pressure, mm Hg (n = 29)     123.61 ± 16.8        116.41 ± 18.46        −7.2             −3.376          .001     −5.82
  Diastolic blood pressure, mm Hg (n = 29))   80.26 ± 9.97         73.38 ± 11.18         −6.88            −4.124          \<.000   −8.57
  HRV (n = 25)                                16.72 ± 7.58         14.54 ± 7.46          −2.18            −0.888          .374     −13.04
  Heart coherence (n = 25)                    65.34 ± 17.55        69.75 ± 15.24         4.41             −1.332          .183     6.75
  SigA, μg/mL (n = 28)                        112.58 ± 119.37      181.73 ± 155.32       69.15            −2.391          .017     61.42
  Cortisol, nmol/L (n = 28)                   12.66 ± 5.84         6.51 ± 2.81           −6.15            −4.213          \<.000   −48.58

Abbreviations: HRV, heart rate variability; PTSD, posttraumatic stress disorder; SigA, salivary immunoglobulin A.

![Score changes following treatment in study participants. Outliers within each group are represented by the black dots. DBP, diastolic blood pressure; HC, heart coherence; HRV, heart rate variability; PTSD, posttraumatic stress disorder; SBP, systolic blood pressure; SigA, salivary immunoglobulin A.](10.1177_2515690X18823691-fig1){#fig1-2515690X18823691}

Between the pre and follow-up time points, participants experienced significant decreases in anxiety, depression, PTSD, and pain (see [Table 4](#table4-2515690X18823691){ref-type="table"}). All changes were statistically significant with the exception of happiness.

###### 

Participant Outcome Measures Pre- Versus Follow-up Intervention.

![](10.1177_2515690X18823691-table4)

  Scale                                    Pretest, Mean ± SD   Follow-up, Mean ± SD   Change in Mean   *Z* Statistic   *P*      Percent Change
  ---------------------------------------- -------------------- ---------------------- ---------------- --------------- -------- ----------------
  Happiness (n = 85)                       7.28 ± 2.10          7.70 ± 2.09            0.42             −1.581          .114     5.77
  Anxiety (n = 84)                         8.35 ± 3.85          5.62 ± 3.74            −2.73            −5.276          \<.000   −32.69
  Depression (n = 84)                      4.04 ± 3.18          2.78 ± 2.93            −1.26            −3.083          .002     −31.18
  Posttraumatic stress disorder (n = 72)   4.74 ± 2.16          3.64 ± 1.73            −1.10            −4.088          \<.000   −23.21
  Pain (n = 85)                            4.09 ± 2.49          2.66 ± 2.26            −1.43            −4.681          \<.000   −34.96

Dissimilar results were found between post and follow-up time points, with anxiety and pain found to significantly increase, while happiness decreased significantly (see [Table 5](#table5-2515690X18823691){ref-type="table"}).

###### 

Participant Outcome Measures Post Versus Follow-up Intervention

![](10.1177_2515690X18823691-table5)

  Scale                                    Posttest, Mean ± SD   Follow-up, Mean ± SD   Change in Mean   *Z* Statistic   *P*      Percent Change
  ---------------------------------------- --------------------- ---------------------- ---------------- --------------- -------- ----------------
  Happiness (n = 89)                       8.65 ± 1.72           7.70 ± 2.09            −0.95            −4.410          \<.000   −10.98
  Anxiety (n = 84)                         4.98 ± 3.43           5.62 ± 3.74            0.64             −3.294          .001     12.85
  Depression (n = 84)                      2.30 ± 2.28           2.78 ± 2.93            0.48             −1.091          .275     20.87
  Posttraumatic stress disorder (n = 77)   3.30 ± 1.49           3.64 ± 1.73            0.34             −1.662          .097     10.30
  Pain (n = 87)                            1.63 ± 1.89           2.66 ± 2.26            1.03             −3.790          \<.000   63.19

The correlations among psychological measures were calculated to determine their interaction (see [Table 6](#table6-2515690X18823691){ref-type="table"}). Significant positive correlations were found between pre and post intervention measures of happiness, anxiety, depression, pain, and cravings. Significant negative correlations were found between happiness and all measures except cravings at both time points.

###### 

Correlation Between Outcome Measures Pre- Versus Postintervention

![](10.1177_2515690X18823691-table6)

                  Happiness   Anxiety   Depression   PTSD      Pain      Cravings   Happiness^a^   Anxiety^a^   Depression^a^   PTSD^a^   Pain^a^   Cravings^a^   Age
  --------------- ----------- --------- ------------ --------- --------- ---------- -------------- ------------ --------------- --------- --------- ------------- --------
  Happiness       1           −.483\*   −.589\*      −.392\*   −.215\*   −.009      .595\*         −.417\*      −.499\*         −.289\*   −.091     −.047         .013
  Anxiety         −.483\*     1         .515\*       .467\*    .372\*    .050       −.282\*        .652\*       .320\*          .398\*    .249\*    .045          −.109
  Depression      −.589\*     .515\*    1            .396\*    .218\*    −.106      −.364\*        .318\*       .646\*          .321\*    .055      .003          −.033
  PTSD            −.392\*     .467\*    .396\*       1         .366\*    −.029      −.155          .250\*       .239\*          .482\*    .133      −.054         −.034
  Pain            −.215\*     .372\*    .218\*       .366\*    1         .018       −.125          .201\*       .037            .220\*    .369\*    −.013         .134
  Cravings        −.009       .050      −.106        −.029     .018      1          .007           .097         −.027           .125      .019      .384\*        .047
  Happiness^a^    .595\*      −.282\*   −.364\*      −.155     −.125     .007       1              −.492\*      −.523\*         −.348\*   −.354\*   −.051         .038
  Anxiety^a^      −.417\*     .652\*    .318\*       .250\*    .201\*    .097       −.492\*        1            .559\*          .501\*    .364\*    .022          −.113
  Depression^a^   −.499\*     .320\*    .646\*       .239\*    .037      −.027      −.523\*        .559\*       1               .399\*    .246\*    .012          −.057
  PTSD^a^         −.289\*     0.398\*   .321\*       .482\*    .220\*    .125       −.348\*        .501\*       .399\*          1         .377\*    .002          −.137
  Pain^a^         −.091       .249\*    .055         .133      .396\*    .019       −.354\*        .364\*       .246\*          .377\*    1         −.054         −.036
  Cravings^a^     −.047       .045      .003         −.054     −.013     .384\*     −.051          .022         .012            .002      −.054     1             −.015
  Age             .013        −.109     −.033        −.034     .134      .047       .038           −.113        −.057           −.137     −.036     −.015         1
  Mean            7.28        8.35      4.04         4.74      4.09      6.47       8.65           4.98         2.30            3.30      1.63      1.81          50.45
  SD              2.098       3.853     3.178        2.16      2.489     2.534      1.715          3.427        2.279           1.49      1.889     1.807         12.346
  n               182         179       179          170       182       165        178            176          176             165       175       165           187

Abbreviation: PTSD, posttraumatic stress disorder.

^a^ Postintervention.

\**P* = .01. \*\**P* = .05.

The correlations among psychological and physiological measures in the subset of individuals who completed both assessments (n = 31) were also calculated to determine their interaction (see [Table 7](#table7-2515690X18823691){ref-type="table"}). Significant positive correlations were found between pre- and postintervention measures of anxiety and cortisol. Significant negative correlations were found between happiness and anxiety, PTSD, pain at preintervention, and only pain at postintervention.

###### 

Subset of Participants Correlation Between Outcome Measures Pre- Versus Postintervention (N = 31).

![](10.1177_2515690X18823691-table7)

                  Happiness   Anxiety     Depression   PTSD       Pain        Cravings   SigA     Cortisol   Happiness^a^   Anxiety^a^   Depression^a^   PTSD^a^     Pain^a^   Cravings^a^   SigA^a^    Cortisol^a^   Age
  --------------- ----------- ----------- ------------ ---------- ----------- ---------- -------- ---------- -------------- ------------ --------------- ----------- --------- ------------- ---------- ------------- -------
  Happiness       1           −.516\*     −.259        −.708\*    −.476\*     −.220      .151     .291       .296           −.183        .061            −.174       −.489\*   .169          .116       .025          −.069
  Anxiety         −.516\*     1           .510\*       .647\*     .441\*\*    .218       −.062    .077       −.422\*\*      .595\*       .199            .427\*      .527\*    .084          −.062      −.038         .188
  Depression      −.259       .510\*      1            .343       .157        .048       −.120    −.059      −.089          .227         .204            .288        −.100     −.197         −.022      −.179         .026
  PTSD            −.708\*     .647\*      .343         1          .451\*\*    .151       −.052    −.076      −.244          .287         .073            .304        .298      −.037         −.073      −.087         −.264
  Pain            −.476\*     .441\*\*    .157         .451\*\*   1           .218       .260     −.056      −.034          −.075        −.368\*\*       −.109       .227      .041          .155       −.142         .156
  Cravings        −.220       .218        .048         .151       .218        1          .211     −.046      −.249          .296         .039            .302        .213      .031          .469\*\*   .227          −.008
  SigA            .151        −.062       −.120        −.052      .260        .211       1        −.073      .047           −.143        −.095           −.038       −.179     .163          .289       .326          −.064
  Cortisol        .291        .077        −.059        −.076      −.056       −.046      −.073    1          −.057          −.072        .178            .177        .000      .015          .018       .381\*\*      −.005
  Happiness^a^    .296        −.422\*\*   −.089        −.244      −.034       −.249      .047     −.057      1              −.626\*      −.533\*         −.416\*\*   −.704\*   .246          −.034      −.059         .156
  Anxiety^a^      −.183       .595\*      .227         .287       −.075       .296       −.143    −.072      −.626\*        1            .596\*          .564\*      .596\*    .073          .035       −.085         −.067
  Depression^a^   .061        .199        .204         .073       −.368\*\*   .039       −.095    .178       −.533\*        .596\*       1               .417\*\*    .228      −.228         .083       .021          −.288
  PTSD^a^         −.174       .427\*\*    .288         .304       −.109       .302       −.038    .177       −.416\*\*      .564\*       .417\*          1           .350      .033          −.120      .090          .011
  Pain^a^         −.489\*     .527\*      −.100        .298       .227        .213       −.179    .000       −.704\*        .596\*       .228            .350        1         −.007         −.036      .007          .308
  Cravings^a^     .169        .084        −.197        −.037      .041        .031       .163     .015       .246           .073         −.228           .033        −.007     1             .223       .050          .211
  SigA^a^         .116        −.062       −.022        −.073      .155        .469\*\*   .289     .018       −.034          .035         .083            −.120       −.036     .223          1          .237          .221
  Cortisol^a^     .025        −.038       −.179        −.087      −.142       .227       .326     .381\*\*   −.059          −.085        .021            .090        .007      .050          .237       1             .149
  Age             −.069       .188        .026         −.264      .156        −.008      −.064    −.005      .156           −.067        −.288           .011        .308      .211          .221       .149          1
  Mean            7.9         6.32        2.68         4.59       3.9         6.72       112.58   12.66      9.03           3.84         1.45            3.14        1.34      1.36          181.73     6.51          52.88
  SD              1.92        3.89        2.29         2.01       2.35        2.73       119.37   5.84       1.27           3.17         1.61            1.46        1.69      1.25          155.32     2.81          16.05
  n               30          31          31           29         30          25         28       28         29             31           31              28          29        25            28         28            26

Abbreviations: PTSD, posttraumatic stress disorder; SigA, salivary immunoglobulin A.

^a^ Postintervention.

\**P* = .01. \*\**P* = .05.

Discussion {#section12-2515690X18823691}
==========

This study adds to the evidence base for EFT as an effective mental health intervention, as has been demonstrated in many previous studies. It also suggests that EFT simultaneously improves a broad range of health markers across multiple physiological systems. As hypothesized, participants experienced significant decreases in pain, anxiety, depression, and PTSD. Physiological indicators of health such as RHR, BP, and cortisol also significantly decreased, indicating improvement. Happiness levels increased as did immune system function.

The current research findings of each of the physiological measures has potential and far-reaching health consequences. Decreases in cortisol have been associated with a wide spectrum of positive health effects, including increased muscle mass, increased bone density, improved skin elasticity, enhancement of cognitive function especially learning and attention, and enhanced cell signaling^[@bibr61-2515690X18823691]^ This was the first study to assess SigA, HRV, HC, BP, and RHR after EFT treatment. The results are consistent with previous research demonstrating improvements in endocrinal and genetic regulation.^[@bibr10-2515690X18823691],[@bibr42-2515690X18823691],[@bibr46-2515690X18823691]^

The 74% reduction in cravings *(P* \< .000) is typical of that found in other EFT research.^[@bibr18-2515690X18823691],[@bibr11-2515690X18823691],[@bibr13-2515690X18823691],[@bibr62-2515690X18823691]^ While not statistically significant, the trends toward improvement in HRV and HC allude to possible improvements in cardiovascular health and ANS function. A power analysis was performed, and it was determined that detection of a medium effect size change for HC and HRV at a significance level of .05 and 90% power would require a minimum of 44 participants.

The improvements found in RHR and BP were clinically as well as statistically significant. If these were available to hospital patients as well as therapy group participants, medical services utilizations would be reduced. The savings in terms of financial cost and human suffering would be substantial. For example, outpatient psychotherapy has been shown to be effective in terms of symptom reduction and the improvement of quality of life, and to decrease work disability days, hospitalization days, and inpatient costs.^[@bibr63-2515690X18823691]^ A meta-analysis of 91 studies, which examined a range of psychological treatments (various forms of psychotherapy, behavioral medicine, and psychiatric consultation), found the average savings resulting from using psychological interventions was estimated to be about 20%.^[@bibr64-2515690X18823691]^ The review also reported that even when the cost of providing the psychological intervention was subtracted, it was still this substantial saving. Clearly, there is something to be gained from including psychological interventions.

While the psychological improvements produced by EFT have been extensively studied (eg, large effect sizes for EFT in the treatment of anxiety \[Clond\],^[@bibr30-2515690X18823691]^ depression \[Nelms & Castel\],^[@bibr31-2515690X18823691]^ and PTSD \[Sebastian & Nelms\]), the extension of research into their physiological dimensions is relatively new. When approaches such as EFT are noninvasive, nonpharmaceutical, and free of negative side effects are resulting in such profound changes for a person, they may demand further consideration as frontline medical interventions. Users report Clinical EFT can be learned quickly and applied easily, and is well-tolerated in heterogeneous populations, makes a simple nondrug therapy available to a large population. Its use in and outside clinical settings as a safe and reliable method for reducing distress,^[@bibr7-2515690X18823691]^ and for a wide range of psychological and physical symptoms, makes it a useful strategy to add to existing protocols. The profound physiological changes that also occur with this technique, is establishing EFT as safe and effective with a variety of populations and conditions.

Limitations {#section13-2515690X18823691}
-----------

Despite the positive results, the study had a number of limitations. One was the absence of a control or comparison group. Others included reliance on self-report for psychological measures, the low number of participants who completed follow-up assessments (89 out of 203) and the use of relatively brief assessments. The effects obtained could have been partially due to nonspecifics present in any therapy, to the supportive nature of the group, to demand characteristics, or to sympathetic attention. Completers of the follow-up assessments (44%) might not have been representative of the sample as a whole. Because of the small sample size, statistical significance was not obtained for HC or HRV. The reliable measurement of HRV is also in its infancy and requires further validation to be considered a sound procedure.

Further research should also randomize participants between EFT and an active control treatment such as CBT and include at least 44 persons per group in order to identify statistically significant changes in all physiological markers. EFTs epigenetic effects could be further explored with use of salivary gene assays such as were used in Maharaj^[@bibr46-2515690X18823691]^ and similar studies. A larger battery of psychological assessments could be used, and a second follow-up data point included to determine trends over time.

Despite these limitations, this study points to the multidimensional physiological effects of EFT as well as its utility for improving emotional health when delivered in group format. Group therapy is efficient and cost-effective, and similar results were found when different trainers taught Clinical EFT, showing that the improvements measured were not due to the unique gifts of a particular therapist.

Conclusions {#section14-2515690X18823691}
===========

Reviews and meta-analyses of EFT demonstrate that it is an evidence-based practice^[@bibr7-2515690X18823691],[@bibr44-2515690X18823691]^ and that its efficacy for anxiety, depression, phobias and PTSD is well-established. The research investigating physiological improvements after EFT intervention is limited; however, this study adds to the body of literature and suggests that EFT is associated with multidimensional improvements across a spectrum of physiological systems.
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